Nasal-Delivery Decongestants . Nasal-delivery decongestants are applied directly into the nasal passages with a spray, gel, drops, or vapors. Nasal decongestants come in long-acting or short-acting forms. The effects of short-acting decongestants last about 4 hours; long-acting decongestants last 6 - 12 hours. The active ingredients in nasal decongestants include oxymetazoline, xylometazoline, and phenylephrine. Nasal forms work faster than oral decongestants and may not cause as much drowsiness. However, they can cause dependency and rebound.
One of the most crucial components of a MDI is its propellant. The propellant provides the force to generate the aerosol cloud and is also the medium in which the active component must be suspended or dissolved. Propellants in MDIs typically make up more than 99% of the delivered dose,  so it is the properties of the propellant that dominate more than any other individual factor. This is often overlooked in literature and in industry because so few propellants are used and their contribution is often taken for granted. Suitable propellants must pass a stringent set of criteria, they must:
The sponsors of have years of experience in providing care to adults and children with asthma . They don’t prescribe drugs, like asthma inhalers, with dangerous side effects that only address the symptoms of conditions. No, they go right to the source and try to identify the cause, so that you can heal from the inside out, not the outside in. Outside in (using an asthma inhaler to “fix” your asthma problem) – that’s just not true healing, it’s a band-aid on the problem and it will eventually fall off. When it does, the problem will still be there, and maybe they’ll be another one, in the form of a side effect, that might require another drug. Is that really the way you want to live? Is that really the way you want your child to live?